BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15758556)

  • 1. Studies of very severe short stature with severe GH deficiency: from the data registered with the foundation for growth science.
    Hanew K; Tachibana K; Yokoya S; Fujieda K; Tanaka T; Igarashi Y; Shimatsu A; Tanaka H; Tanizawa T; Teramoto A; Nishi Y; Hasegawa Y; Hizuka N; Hirano T; Fujita K;
    Endocr J; 2005 Feb; 52(1):37-43. PubMed ID: 15758556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, etiologies and pathophysiology of patients with severe short stature with severe GH deficiency: questionnaire study on the data registered with the foundation for growth science, Japan.
    Hanew K; Tachibana K; Yokoya S; Fujieda K; Tanaka T; Igarashi Y; Shimatsu A; Tanaka H; Tanizawa T; Teramoto A; Nishi Y; Hasegawa Y; Hizuka N; Hirano T; Fujita K
    Endocr J; 2006 Apr; 53(2):259-65. PubMed ID: 16618986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can exaggerated response to a GH provocative test identify patients with partial GH insensitivity syndrome?
    Rakover Y; Silbergeld A; Lavi I; Masalha R; Shlomo IB
    Eur J Endocrinol; 2002 Mar; 146(3):319-23. PubMed ID: 11888837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
    Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial growth hormone deficiency (GHD) in children has more similarities to idiopathic short stature than to severe GHD.
    Smyczyńska J; Lewiński A; Hilczer M; Stawerska R; Karasek M
    Endokrynol Pol; 2007; 58(3):182-7. PubMed ID: 17940982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency.
    Martínez AS; Domené HM; Ropelato MG; Jasper HG; Pennisi PA; Escobar ME; Heinrich JJ
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4168-72. PubMed ID: 11095449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth weight affects final height in patients treated for growth hormone deficiency.
    Cacciari E; Zucchini S; Cicognani A; Pirazzoli P; Balsamo A; Salardi S; Cassio A; Pasini A; Gualandi S
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):733-9. PubMed ID: 10619978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
    Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
    Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood.
    Attanasio AF; Howell S; Bates PC; Blum WF; Frewer P; Quigley C; Shalet SM
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):503-7. PubMed ID: 11966743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades.
    Ranke MB; Schweizer R; Binder G
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1257-1266. PubMed ID: 30332395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.